Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma

BACKGROUND & AIMS: Sorafenib is a multireceptor tyrosine kinase inhibitor that can prolong overall survival in patients with advanced hepatocellular carcinoma (HCC). Although most HCC patients who receive sorafenib ultimately show disease progression, it still is unclear whether and how HCC cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashiba, Tomomi, Yamashita, Taro, Okada, Hikari, Nio, Kouki, Hayashi, Takehiro, Asahina, Yoshiro, Hayashi, Tomoyuki, Terashima, Takeshi, Iida, Noriho, Takatori, Hajime, Shimakami, Tetsuro, Kawaguchi, Kazunori, Arai, Kuniaki, Sakai, Yoshio, Yamashita, Tatsuya, Mizukoshi, Eishiro, Takamura, Hiroyuki, Ohta, Tetsuo, Honda, Masao, Kaneko, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305345/
https://www.ncbi.nlm.nih.gov/pubmed/32169577
http://dx.doi.org/10.1016/j.jcmgh.2020.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305345/
https://www.ncbi.nlm.nih.gov/pubmed/32169577
http://dx.doi.org/10.1016/j.jcmgh.2020.02.009

Ejemplares similares